Weight Loss & Metabolic

Retatrutide

Triple-agonist metabolic research peptide

Retatrutide is a next-generation triple receptor agonist studied for its combined action on GLP-1, GIP and glucagon pathways. It is a leading focus of current metabolic and body-composition research.

This product is intended strictly for laboratory and research purposes only. Not for human or animal consumption. Not evaluated by the FDA. You must be 21 years or older to purchase.